A Study to Investigate Canvuparatide Compared With Placebo in Adult Patients With Hypoparathyroidism
Recruiting now · Phase 3 · Has a placebo group
Conditions studied: Hypoparathyroidism
In brief
The purpose of this study is to investigate the efficacy and safety of canvuparatide administered as a once-weekly (QW) treatment to adult study participants with hypoparathyroidism (HypoPT).
Key facts
- Study ID
- NCT07699471
- Run by
- MBX Biosciences
- People needed
- 160
- Starts
- 2026-08-01
- Expected to finish
- 2029-08-01
- Last updated by the study team
- 2026-07-13
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- MBX Biosciences Investigational Site — Homestead, Florida, United States (enrolling)
- MBX Biosciences Investigational Site — Shavano Park, Texas, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.